Binding of acarbose, an anti-diabetic drug to lysozyme: a combined structural and thermodynamic study

被引:10
|
作者
Dileep, K. V. [1 ]
Nithiyanandan, K. [1 ]
Remya, C. [2 ]
机构
[1] Indian Inst Sci Educ & Res, Sch Chem, Sreekaryam, Kerala, India
[2] Kannur Univ, Dept Biotechnol & Microbiol, Kannur, Kerala, India
来源
关键词
acarbose; hereditary systemic amyloidosis; lysozyme aggregation; molecular docking; molecular dynamics and ITC; EGG-WHITE LYSOZYME; AGGREGATION; INHIBITORS; MOLECULE;
D O I
10.1080/07391102.2017.1388283
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:3354 / 3361
页数:8
相关论文
共 50 条
  • [31] The role of an anti-diabetic drug metformin in the treatment of endocrine tumors
    Thakur, Shilpa
    Daley, Brianna
    Klubo-Gwiezdzinska, Joanna
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2019, 63 (02) : R17 - R35
  • [32] HOW TO PRESCRIBE AND SUPERVIZE TREATMENT WITH AN ORAL ANTI-DIABETIC DRUG
    PIQUET, V
    [J]. REVUE DE MEDECINE, 1981, 22 (19): : 1137 - &
  • [33] Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPARγ
    Jun Young Jang
    Hwan Bae
    Yong Jae Lee
    Young Il Choi
    Hyun-Jung Kim
    Seung Bum Park
    Se Won Suh
    Sang Wan Kim
    Byung Woo Han
    [J]. Scientific Reports, 8
  • [34] Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPARγ
    Jang, Jun Young
    Bae, Hwan
    Lee, Yong Jae
    Choi, Young Il
    Kim, Hyun-Jung
    Park, Seung Bum
    Suh, Se Won
    Kim, Sang Wan
    Han, Byung Woo
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [35] Identification and structural insight of an effective PPARγ modulator with improved therapeutic index for anti-diabetic drug discovery
    Jiang, Haowen
    Zhou, X. Edward
    Shi, Jingjing
    Zhou, Zhi
    Zhao, Guanguan
    Zhang, Xinwen
    Sun, Yili
    Suino-Powell, Kelly
    Ma, Lei
    Gao, Hui
    Yu, Xiyong
    Li, Jia
    Li, Jingya
    Melcher, Karsten
    Xu, H. Eric
    Yi, Wei
    [J]. CHEMICAL SCIENCE, 2020, 11 (08) : 2260 - 2268
  • [36] Structural and redox requirements for the action of anti-diabetic vanadium compounds
    Yoshikawa, Yutaka
    Sakurai, Hiromu
    Crans, Debbie C.
    Micera, Giovanni
    Garribba, Eugenio
    [J]. DALTON TRANSACTIONS, 2014, 43 (19) : 6965 - 6972
  • [37] Long-acting anti-diabetic peptide drug based on genetic fusion with an albumin-binding aptide
    Kim, S.
    [J]. NEW BIOTECHNOLOGY, 2018, 44 : S143 - S144
  • [38] The high prevalence of malnutrition in elderly diabetic patients: implications for anti-diabetic drug treatments
    Vischer, U. M.
    Perrenoud, L.
    Genet, C.
    Ardigo, S.
    Registe-Rameau, Y.
    Herrmann, F. R.
    [J]. DIABETIC MEDICINE, 2010, 27 (08) : 918 - 924
  • [39] Predetermined Anti-Diabetic Drug Regimen Adjustments during Ramadan Fasting: An Observational Study of Safety
    Beano, Abdallah M.
    Zmaili, Mohammad A.
    Gheith, Zaid H.
    Naser, Ahmad M.
    Momani, Munther S.
    Yousef, Al-Motassem F.
    Zayed, Ayman A.
    [J]. ENDOCRINOLOGY AND METABOLISM, 2017, 32 (02) : 265 - 273
  • [40] In vivo hypoglycemic and anti-diabetic study of Oncocalyx glabratus
    Ahmed, Sarfaraz
    Mothana, Ramzi A.
    Al-Rehaily, Adnan J.
    [J]. BANGLADESH JOURNAL OF PHARMACOLOGY, 2015, 10 (04) : 830 - 835